Wholesale of pharmaceutical and medical goods
EMBECTA NORWAY AS
Revenue 2024
NOK 15.8m
Operating profit
NOK 606,000
Equity
NOK 7.7m
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2025
Current ratio
3.79
Equity ratio
77.0%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 3.8% | |
| Net margin (%%) | 0.9% | |
| Return on assets (%%) | 6.1% | |
| Likviditet | ||
| Current ratio | 3.79 | |
| Working capital | 6.4m | |
| Soliditet | ||
| Equity ratio (%%) | 77.0% | |
| Debt-to-equity ratio | 0.30 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.